Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Other financing activities (2016 - 2025)

Historic Other financing activities for LifeMD (LFMDP) over the last 10 years, with Q3 2025 value amounting to $3.2 million.

  • LifeMD's Other financing activities rose 3357.24% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year decrease of 1431.9%. This contributed to the annual value of $12.2 million for FY2024, which is 203.81% down from last year.
  • According to the latest figures from Q3 2025, LifeMD's Other financing activities is $3.2 million, which was up 3357.24% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Other financing activities registered a high of $4.5 million during Q1 2022, and its lowest value of $1.9 million during Q4 2022.
  • In the last 5 years, LifeMD's Other financing activities had a median value of $3.1 million in 2024 and averaged $3.0 million.
  • Data for LifeMD's Other financing activities shows a peak YoY increase of 232520.86% (in 2021) and a maximum YoY decrease of 8100.49% (in 2021) over the last 5 years.
  • LifeMD's Other financing activities (Quarter) stood at $3.1 million in 2021, then tumbled by 39.42% to $1.9 million in 2022, then skyrocketed by 93.44% to $3.6 million in 2023, then fell by 14.83% to $3.1 million in 2024, then increased by 3.0% to $3.2 million in 2025.
  • Its last three reported values are $3.2 million in Q3 2025, $2.1 million for Q2 2025, and $2.5 million during Q1 2025.